Sembol | Piyasa Değeri | Fiyat | Değişim % | Hacim | Bağ Hacim | FKO | EPS Seyreltilmiş TTM | EPS Seyreltilmiş Büyüme TTM YY | Tmt getirisi % TTM | Analist Değerlendirmesi |
---|---|---|---|---|---|---|---|---|---|---|
BMKBENCHMARK HLDGS PLC | 3,21 B NOK | 5,30 NOK | +4,95% | 6 K | 1,72 | — | −0,60 NOK | −66,47% | 0,00% | Güçlü al |
MEDIMEDISTIM ASA | 2,78 B NOK | 152,5 NOK | 0,00% | 3,4 K | 0,98 | 27,48 | 5,55 NOK | −13,40% | 2,95% | Nötr |
PHOPHOTOCURE ASA | 1,59 B NOK | 58,5 NOK | −4,10% | 98,3 K | 1,02 | 117,87 | 0,50 NOK | — | 0,00% | Güçlü al |
VISTNVISTIN PHARMA ASA | 1,04 B NOK | 23,4 NOK | −1,27% | 8,31 K | 1,51 | 16,90 | 1,39 NOK | +37,91% | 4,27% | — |
NYKDNYKODE THERAPEUTICS ASA | 988,13 M NOK | 3,026 NOK | −5,91% | 1,86 M | 0,99 | — | −1,22 NOK | +17,44% | 0,00% | Al |
AZTARCTICZYMES TECHNOLOGIES ASA | 718,06 M NOK | 14,06 NOK | +1,01% | 30,82 K | 0,39 | 113,48 | 0,12 NOK | −64,58% | 0,00% | Al |
GGENTGENTIAN DIAGNOSTICS ASA | 616,89 M NOK | 40,0 NOK | −4,31% | 1,54 K | 0,93 | 275,48 | 0,15 NOK | — | 0,00% | Güçlü al |
LYTIXLYTIX BIOPHARMA AS | 400,78 M NOK | 5,88 NOK | −1,34% | 30,63 K | 0,03 | — | −1,85 NOK | +24,63% | 0,00% | — |
BGBIOBERGENBIO ASA | 355,58 M NOK | 9,097 NOK | −6,01% | 381,23 K | 1,88 | — | −4,91 NOK | +85,91% | 0,00% | Güçlü al |
EEXTXEXACT THERAPEUTICS AS | 239,14 M NOK | 3,78 NOK | +3,85% | 28,66 K | 0,54 | — | −1,71 NOK | −42,45% | 0,00% | — |
LIFELIFECARE ASA | 202,13 M NOK | 12,75 NOK | +1,19% | 10,44 K | 0,20 | — | −15,43 NOK | −634,96% | 0,00% | — |
ULTIULTIMOVACS ASA | 83,78 M NOK | 2,435 NOK | −1,02% | 164,8 K | 0,19 | — | −4,34 NOK | +26,84% | 0,00% | Nötr |
PCIBPCI BIOTECH HOLDING ASA | 51,81 M NOK | 1,388 NOK | +1,76% | 75,42 K | 0,49 | — | — | — | 0,00% | — |
AABSARCTIC BIOSCIENCE AS | 47,95 M NOK | 1,89 NOK | −1,56% | 29,56 K | 0,76 | — | −1,91 NOK | −19,37% | 0,00% | Nötr |
CCRNACIRCIO HOLDING ASA | 38,2 M NOK | 0,730 NOK | +1,39% | 681,76 K | 0,47 | 0,85 | 0,86 NOK | — | 0,00% | Nötr |
OONCINONCOINVENT ASA | — | 3,21 NOK | +0,31% | 17,07 K | 0,07 | — | — | — | — | — |